Related references
Note: Only part of the references are listed.Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project
John Paget et al.
VACCINE (2022)
Excess hospitalizations and mortality associated with seasonal influenza in Portugal, 2008-2018
Filipe Froes et al.
BMC INFECTIOUS DISEASES (2022)
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
Lisa A. Grohskopf et al.
MMWR Recommendations and Reports (2022)
The disease burden of influenza beyond respiratory illness
Alejandro E. Macias et al.
VACCINE (2021)
Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature review
Florian Colrat et al.
VACCINE (2021)
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial
Stephanie Pepin et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine
Esther Redondo et al.
VACCINE (2021)
Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales
Richard Mattock et al.
JOURNAL OF MEDICAL ECONOMICS (2021)
Variability in published rates of influenza-associated hospitalizations: A systematic review, 2007-2018
Katherine M. Roguski et al.
JOURNAL OF GLOBAL HEALTH (2020)
Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease
Robertus van Aalst et al.
VACCINE (2019)
Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults ≥65 years of age: A phase 3 randomized clinical trial
Lee-Jah Chang et al.
VACCINE (2019)
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis
Jason K. H. Lee et al.
EXPERT REVIEW OF VACCINES (2018)
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
A. Danielle Iuliano et al.
LANCET (2018)
Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis
Mitchell P. Somes et al.
VACCINE (2018)
Influenza-like illness as a trigger for ischemic stroke
Amelia K. Boehme et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
Debbie L. Becker et al.
Human Vaccines & Immunotherapeutics (2016)
Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study
Marc Baguelin et al.
BMC MEDICINE (2015)
Impact of influenza vaccination on mortality in the French elderly population during the 2000-2009 period
Isabelle Bonmarin et al.
VACCINE (2015)
Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines
Carlos A. DiazGranados et al.
VACCINE (2015)
Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors
Ayman Chit et al.
VACCINE (2015)
The role of influenza in the epidemiology of pneumonia
Sourya Shrestha et al.
Scientific Reports (2015)
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Carlos A. DiazGranados et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The valuation of the EQ-5D in Portugal
Lara N. Ferreira et al.
QUALITY OF LIFE RESEARCH (2014)
Estimating influenza vaccine effectiveness using routinely collected laboratory data
D. M. Fleming et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2010)
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Time lines of infection and disease in human influenza: A review of volunteer challenge studies
Fabrice Carrat et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Complications of viral influenza
Michael B. Rothberg et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Swedish population health-related quality of life results using the EQ-5D
K Burstrom et al.
QUALITY OF LIFE RESEARCH (2001)